How do you counsel patients with metastatic TNBC on their various treatment options after progression on first line regimens?  

To what degree do you factor in patient preference when choosing among available treatments? Are there features of each regimen that you emphasize in helping to weigh options?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution